You are here: Home FDA Issues Final Rule Addressing Safety Reporting Requirements
Document Actions
  • Send this page to somebody
  • Print this page

FDA Issues Final Rule Addressing Safety Reporting Requirements

Last modified September 28, 2010 05:58 PM - EST

Today the Food and Drug Administration (FDA) issued a final rule addressing the safety reporting requirements for investigational new drug applications (INDs). Of note, CTTI is conducting a project focused on sponsor reporting of unexpected serious adverse events (SAEs) to investigators during the conduct of a clinical trial. The ultimate objective of the project is to develop a set of recommendations for optimal reporting of SAEs to investigators that will improve human subject protection.


This site conforms to the following standards:

  • Powered by Plone, the Open Source Content Management System
  • Section 508
  • WCAG
  • Valid XHTML
  • Valid CSS
  • Usable in any browser

Sensasi Bermain Seru di Slot Depo 5k dengan Modal Kecil

Slot Depo 5k memberikan sensasi bermain yang tidak kalah dengan slot lainnya, meskipun dengan modal kecil. Pemain dapat menikmati berbagai fitur permainan dengan peluang kemenangan besar, semuanya dengan hanya 5 ribu sebagai deposit awal.

Related Links

Resource Links